BioMarin Pharmaceutical Inc. (BMRN) Shares Bought by Synovus Financial Corp

Marco Green
September 13, 2017

Jefferies maintained BioMarin Pharmaceutical Inc.

Shares of BioMarin Pharmaceutical Inc. Goldman Sachs Group accumulated 1.38M shares. Biomarin Pharmaceutical Inc Com Stk now has $15.99B valuation. It is down 5.29% since September 8, 2016 and is uptrending. It has underperformed by 11.41% the S&P500.

BioMarin Pharmaceutical Inc. (BMRN) exchanged hands at an unexpectedly low level of 0.84 million shares over the course of the day. Therefore 68% are positive. The stock presently has an average rating of "Hold" and a consensus target price of $109.22. The rating was maintained by Deutsche Bank with "Buy" on Thursday, July 13. They issued a "buy" rating and a $98.00 price objective for the company. As per Wednesday, November 18, the company rating was initiated by Goldman Sachs. (NASDAQ:BMRN) has "Neutral" rating given on Tuesday, August 25 by Wedbush. Cowen & Co maintained BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on Thursday, November 3 with "Buy" rating. It also upped Delta Air Lines Inc (Call) stake by 169,500 shares and now owns 199,900 shares. The firm earned "Buy" rating on Monday, June 26 by BMO Capital Markets. On Monday, November 7 the stock rating was downgraded by PiperJaffray to "Neutral". The company was maintained on Tuesday, August 25 by Wedbush. The rating was maintained by J.P. Morgan with "Buy" on Tuesday, July 11.

Since March 9, 2017, it had 0 insider buys, and 18 sales for $9.56 million activity. BIENAIME JEAN JACQUES had sold 5,000 shares worth $441,900. LAWLIS V BRYAN sold $337,500 worth of BioMarin Pharmaceutical Inc. Finally, Canada Pension Plan Investment Board raised its stake in shares of BioMarin Pharmaceutical by 284.2% during the 1st quarter. Over the last ninety days, insiders sold 31,265 shares of company stock valued at $2,905,530. Davis George Eric sold $862,230 worth of stock or 9,471 shares. SPIEGELMAN DANIEL K sold 1,989 shares worth $182,908. FUCHS HENRY J sold $1.35M worth of stock or 15,000 shares. "(NASDAQ:BMRN)" was reported by Week Herald and is the property of of Week Herald.

The value of the investment in (BMRN) increased from $292,000 to $275,000,000 a change of 94,078.1% quarter over quarter. Its down 0.62, from 1.66 in 2016Q3. It increased, as 50 investors sold BMRN shares while 129 reduced holdings. Aperio Group LLC raised its position in shares of BioMarin Pharmaceutical by 9.7% in the second quarter. The biotechnology company reported ($0.21) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.22) by $0.01. It now has negative earnings. Oppenheimer & Company holds 115,960 shares or 0.12% of its portfolio. Finally, BidaskClub lowered shares of BioMarin Pharmaceutical from a "sell" rating to a "strong sell" rating in a research report on Thursday, August 17th. (NASDAQ:BMRN) or 1,989 shares. 567,799 are held by Eaton Vance Mgmt.

Finepoint Capital Lp holds 25.32% of its portfolio in YPF SA (ADR) for 3.28 million shares. Credit Suisse Ag has 429,369 shares. Spot Trading Llc has 0% invested in BioMarin Pharmaceutical Inc.

02/07/2017 - Morgan Stanley began new coverage on BioMarin Pharmaceutical Inc. giving the company a "overweight" rating. (NASDAQ:BMRN) news were published by: Streetinsider.com which released: "Citi Starts BioMarin Pharmaceutical Inc". (NASDAQ:BMRN). Comerica Comml Bank owns 7,099 shares or 0% of their United States portfolio. (NASDAQ:BMRN) on Friday, June 16. The insider Plaumann Mark Lawrence sold $101,524.

Analysts are speculating a 22.19% move, based on the high target price ($50) for the shares that is set to reach in the next 12 months. (NASDAQ:BMRN) for 156,598 shares. 240 The Ensign Group, Inc. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and fifteen have issued a buy rating to the stock. Therefore 50% are positive. Ensign Group had 11 analyst reports since August 5, 2015 according to SRatingsIntel. The company was initiated on Wednesday, August 30 by Citigroup. RBC Capital Markets maintained the stock with "Outperform" rating in Friday, February 26 report. KeyBanc Capital Markets initiated the shares of FANG in report on Friday, August 14 with "Overweight" rating. The stock of The Ensign Group, Inc. The rating was downgraded by JMP Securities to "Mkt Underperform" on Wednesday, January 4. As per Monday, August 21, the company rating was maintained by Northland Capital. The firm has "Neutral" rating given on Thursday, September 3 by Macquarie Research. The firm earned "Buy" rating on Tuesday, February 16 by Stifel Nicolaus. The company has market cap of $3.94 billion.

Investors sentiment decreased to 1.4 in 2016 Q4. Its up 0.24, from 1.32 in 2016Q3. South Dakota Council has 64,800 shares. Moreover, Exane Derivatives has 0% invested in Diamondback Energy Inc (NASDAQ:FANG). (NASDAQ:ENSG). New York State Common Retirement Fund owns 51,900 shares. The Georgia-based Earnest Partners Llc has invested 0.64% in the stock. (NASDAQ:BMRN). Asset Mgmt One Ltd invested in 0.06% or 285,935 shares. Incline Global Management Llc owns 630,854 shares or 3.89% of their USA portfolio. First Interstate Comml Bank holds 0% or 759 shares. Following the sale, the director now directly owns 19,660 shares of the company's stock, valued at $1,769,400. Silvercrest Asset Mngmt Gp Ltd Liability Corp reported 0% in Parsley Energy Inc (NYSE:PE). Bard Associate reported 134,620 shares. Hodges Incorporated has invested 1.02% of its portfolio in Diamondback Energy Inc (NASDAQ:FANG). (NASDAQ:ENSG) for 50 shares.

Lombardia Capital Partners Llc increased Domtar Corporation (NYSE:UFS) stake by 280,963 shares to 426,801 valued at $16.66 million in 2016Q4. Parallel Advisors LLC now owns 1,042 shares of the biotechnology company's stock valued at $100,000 after acquiring an additional 125 shares in the last quarter. Wal (NYSE:WMT) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER